Consumer Health Diabetes

FDA Clears DyAnsys Neurostimulation Device First Relief to treat Diabetic Neuropathic Pain

The wearable device placed on the ear administers continuous pulses of a low-level electrical current over several days. With the FDA clearance of First R...

 July 18, 2022 | News

Mesh Bio and MultiOmic Health partner to advance precision medicines and diagnostics for chronic metabolic disease in Asia with AI

Mesh will collaborate with its network of healthcare provider customers to recruit patients for the study. MultiOmic will generate genomic, proteomic, meta...

 June 30, 2022 | News

Sanofi Enters into a Partnering Agreement with Health2Sync

Sanofi K.K. (Head office: Shinjuku-ku, Tokyo; President: Takahiko Iwaya; hereinafter "Sanofi") and Health2Sync. (Head office: Taito-ku, Toky...

 June 28, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close